This may already have been posted but good to see continued strong support from Hashan and Karst Peak who were Neuren's largest holders at $1 and are backing the company to be an attractive M&A target.
https://www.linkedin.com/posts/hashan-de-silva_why-analysts-love-these-eight-medtech-stocks-activity-7163321989502283776-z7Ef?utm_source=share&utm_medium=member_desktop
"Neuren Pharmaceuticals Limited has had a very successful 2 years however we still see considerable upside when looking at comparable transactions. Orphan drugs has been a hot area for a while and with neuroscience coming back into focus for big pharma, we see Neuren as an attractive target for M&A."
- Forums
- ASX - By Stock
- NEU
- Merck to acquire Prometheus in a US$ 10.8 b deal
Merck to acquire Prometheus in a US$ 10.8 b deal, page-92
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.72 |
Change
-0.150(0.72%) |
Mkt cap ! $2.648B |
Open | High | Low | Value | Volume |
$20.96 | $21.28 | $20.61 | $4.984M | 239.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 782 | $20.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.72 | 1021 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 782 | 20.610 |
2 | 3495 | 20.600 |
2 | 649 | 20.590 |
2 | 1774 | 20.570 |
1 | 145 | 20.550 |
Price($) | Vol. | No. |
---|---|---|
20.720 | 1021 | 2 |
20.730 | 5256 | 1 |
20.750 | 2517 | 1 |
20.790 | 782 | 1 |
20.800 | 649 | 2 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online